Stereotactic Ablative Radiotherapy achieves better overall survival than surgery for early lung cancer

Patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with Stereotactic Ablative Radiotherapy (SABR) rather than the current standard of care - invasive surgery - according to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news